SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMSSeparation Agreement • March 26th, 2003 • Sangstat Medical Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 26th, 2003 Company Industry Jurisdiction
OPTION AGREEMENTOption Agreement • March 26th, 2003 • Sangstat Medical Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 26th, 2003 Company Industry JurisdictionThis Option Agreement (this “Agreement”) is entered into as of the 8th day of November, 2002 among SangStat Medical Corporation, a Delaware corporation with its principal place of business at 6300 Dumbarton Circle, Fremont, California 94555 (“SMC”), Research Corporation Technologies, Inc., a Delaware not-for-profit corporation with its principal place of business at 101 N. Wilmot Road, Suite 600, Tucson, Arizona 85711 (“RCT”) and Therapeutic Human Polyclonals, Inc., a California corporation, with its principal place of business at 101 N. Wilmot Road, Suite 600, Tucson, Arizona 85711 (the “Company”). SMC and RCT are sometimes hereinafter collectively referred to as the “Investors”.
HEMATOLOGY ALLIANCE AGREEMENTHematology Alliance Agreement • March 26th, 2003 • Sangstat Medical Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 26th, 2003 Company Industry JurisdictionTHIS HEMATOLOGY ALLIANCE AGREEMENT (the “Hematology Alliance Agreement”)is made and entered into effective as of November 8, 2002 (the “Effective Date”) by and between SANGSTAT MEDICAL CORPORATION, a Delaware corporation having its principal place of business at 6300 Dumbarton Circle, Fremont, California, 94555 (“SMC”), and THERAPEUTIC HUMAN POLYCLONALS, INC., a California corporation having its principal place of business at 101 North Wilmot Road, Tucson, Arizona, 85711 (“THP”). SMC and THP are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
hTG COLLABORATION AGREEMENTCollaboration Agreement • March 26th, 2003 • Sangstat Medical Corp • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 26th, 2003 Company Industry JurisdictionTHIS hTG COLLABORATION AGREEMENT (the “hTG Collaboration Agreement”) is made and entered into effective as of November 8, 2002 (the “Effective Date”) by and between SANGSTAT MEDICAL CORPORATION, a Delaware corporation having its principal place of business at 6300 Dumbarton Circle, Fremont, California, 94555 (“SMC”), and THERAPEUTIC HUMAN POLYCLONALS, INC., a California corporation having its principal place of business at 101 North Wilmot Road, Tucson, Arizona, 85711 (“THP”). SMC and THP are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.